Breakthrough in Diabetes Treatment: A New Pill Shows Promising Results

A recent study published in the journal Cell has made a significant breakthrough in the treatment of type 2 diabetes and obesity. Researchers at Karolinska Institutet and Stockholm University have developed a new pill that can help lower blood sugar levels and increase fat burning without reducing appetite or causing muscle loss.

The new treatment takes a completely different approach compared to popular GLP-1 medications like Ozempic, which are delivered by injection and work by influencing appetite signals between the gut and brain. Instead, the experimental drug activates metabolism inside skeletal muscle, improving blood sugar regulation and body composition in animal studies while avoiding several side effects often linked to GLP-1 therapies.

The treatment is taken as a tablet rather than an injection, making it more convenient for patients. In an initial Phase I clinical trial involving 48 healthy volunteers and 25 people with type 2 diabetes, participants tolerated the treatment well.